advertisement
Abstract #28063 Published in IGR 13-1
Evaluation and management of glaucoma after keratoprosthesis
Banitt MCurrent Opinions in Ophthalmology 2011; 22: 133-136
PURPOSE OF REVIEW: To review the causes and treatment of glaucoma in Boston keratoprosthesis (K-pro) recipients. RECENT FINDINGS: Glaucoma exists in up to three-quarters of patients who undergo K-pro surgery. After K-pro placement, intraocular pressure (IOP) is measured by digital palpation, which has been found to be reliable in trained observers. The onset or progression of glaucoma in K-pro patients should be monitored through visual field testing, direct visualization and structural imaging of the optic nerve. Although medical therapy is an option, one-half to three-quarters of K-pro recipients are surgically managed with a glaucoma drainage device (GDD) or, less commonly, cyclophotocoagulation. SUMMARY: Glaucoma is a common and permanent blinding sequelae of K-pro surgery. In K-pro patients, elevated IOP and changes in the optic nerve head should result in a high index of suspicion for glaucoma. Management is frequently surgical and typically entails placement of a GDD. (copyright) 2011 Lippincott Williams & Wilkins, Inc.
M. Banitt. University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136, United States. mbanitt@med.miami.edu
Classification:
9.4.11.4 Glaucomas associated with corneal surgery (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders > 9.4.11 Glaucomas following intraocular surgery)
